1. Home
  2. NVAX vs CAKE Comparison

NVAX vs CAKE Comparison

Compare NVAX & CAKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • CAKE
  • Stock Information
  • Founded
  • NVAX 1987
  • CAKE 1972
  • Country
  • NVAX United States
  • CAKE United States
  • Employees
  • NVAX N/A
  • CAKE N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • CAKE Restaurants
  • Sector
  • NVAX Health Care
  • CAKE Consumer Discretionary
  • Exchange
  • NVAX Nasdaq
  • CAKE Nasdaq
  • Market Cap
  • NVAX 2.0B
  • CAKE 2.0B
  • IPO Year
  • NVAX 1995
  • CAKE 1992
  • Fundamental
  • Price
  • NVAX $9.76
  • CAKE $47.79
  • Analyst Decision
  • NVAX Buy
  • CAKE Hold
  • Analyst Count
  • NVAX 6
  • CAKE 14
  • Target Price
  • NVAX $17.83
  • CAKE $41.38
  • AVG Volume (30 Days)
  • NVAX 7.2M
  • CAKE 1.1M
  • Earning Date
  • NVAX 11-07-2024
  • CAKE 10-29-2024
  • Dividend Yield
  • NVAX N/A
  • CAKE 2.52%
  • EPS Growth
  • NVAX N/A
  • CAKE 82.87
  • EPS
  • NVAX N/A
  • CAKE 2.39
  • Revenue
  • NVAX $987,667,000.00
  • CAKE $3,502,484,000.00
  • Revenue This Year
  • NVAX N/A
  • CAKE $6.24
  • Revenue Next Year
  • NVAX N/A
  • CAKE $5.72
  • P/E Ratio
  • NVAX N/A
  • CAKE $17.90
  • Revenue Growth
  • NVAX N/A
  • CAKE 2.74
  • 52 Week Low
  • NVAX $3.53
  • CAKE $29.27
  • 52 Week High
  • NVAX $23.86
  • CAKE $43.73
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 36.20
  • CAKE 77.12
  • Support Level
  • NVAX $9.52
  • CAKE $40.72
  • Resistance Level
  • NVAX $10.63
  • CAKE $43.51
  • Average True Range (ATR)
  • NVAX 0.57
  • CAKE 1.28
  • MACD
  • NVAX -0.12
  • CAKE 0.52
  • Stochastic Oscillator
  • NVAX 9.97
  • CAKE 99.28

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

About CAKE Cheesecake Factory Incorporated (The)

Cheesecake Factory Inc owns and operates restaurants in the United States and Canada under brands that include The Cheesecake Factory, North Italia, and a collection within the Fox Restaurants Concepts subsidiary. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, other FRC, and Flower Child. Majority of the company's revenue comes from The Cheesecake Factory restaurants segment.

Share on Social Networks: